MedPath
TGA Approval

ABRILADA adalimumab 20 mg solution for injection pre-filled syringe (334496)

334496

ABRILADA adalimumab 20 mg solution for injection pre-filled syringe

Pfizer Australia Pty Ltd

February 22, 2021

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/f07db8cba67c4b07ca63e8a534e736f4.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/58ae2edf739351667cd3d870c97dd4bf.pdf

Active Ingredients

Adalimumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ABRILADA adalimumab 20 mg solution for injection pre-filled syringe (334496) - TGA 批准文号 | MedPath